within Pharmacolibrary.Drugs.ATC.D;

model D06BB08
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.05,
    Cl             = 0.0,
    adminDuration  = 600,
    adminMass      = 0.01,
    adminCount     = 1,
    Vd             = 0.01,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Ibacitabine is a nucleoside analogue with antiviral properties, primarily developed for topical use in the treatment of herpes simplex infections of the skin. It is not currently approved for medical use and is largely of historical research interest.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for adult human topical application, as no primary PK publications exist for ibacitabine.</p><h4>References</h4><ol><li>Wen-Yi Chang, Wei-Ti Kuo, Chun-Yi Wu, Chih-Yuan Lin, Pei-Chia Chan, Chih-Chieh Shen, Ren-Shan Liu, Hsin-Ell Wang, Chuan-Lin Chen,Evaluation of (131/123)I-5-iodo-2'-deoxycytidine as a novel proliferation probe in a tumor mouse model.,Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine,2013<a href='https://pubmed.ncbi.nlm.nih.gov/23602704/'>https://pubmed.ncbi.nlm.nih.gov/23602704/</a></li><li>Chun-Yi Wu, Lin-Shan Chou, Pei-Chia Chan, Chung-Hsien Ho, Ming-Hsien Lin, Chih-Chieh Shen, Ren-Shyan Liu, Wuu-Jyh Lin, Hsin-Ell Wang,Monitoring tumor response with radiolabeled nucleoside analogs in a hepatoma-bearing mouse model early after doxisome(Â®) treatment.,Molecular imaging and biology,2013<a href='https://pubmed.ncbi.nlm.nih.gov/23247923/'>https://pubmed.ncbi.nlm.nih.gov/23247923/</a></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end D06BB08;
